MARATTO

article · Aquaculture Research

Evaluation of dietary chitosan effects on growth performance, immunity, body composition and histopathology of Nile tilapia (<i>Oreochromis niloticus</i>) as well as the resistance to<i>Streptococcus agalactiae</i>infection

In plain language

This study evaluated the effects of adding chitosan to the feed of Nile tilapia, assessing growth performance, body composition, immune response, and resistance to Streptococcus agalactiae infection. Researchers tested three feeding regimes on 180 fish: a control diet with no chitosan, and diets containing either 3 grams or 5 grams of chitosan per kilogram of feed. Fish fed the 5-gram concentration showed significant improvements in growth parameters, feed conversion ratio, and body composition, alongside higher serum protein, albumin, and globulin levels before infection. Following experimental infection with Streptococcus agalactiae, fish receiving chitosan diets exhibited lower liver enzyme levels, indicating reduced tissue stress, and higher lysozyme and bactericidal activities. Notably, mortality was significantly reduced in fish fed 3 grams per kilogram and completely prevented in those fed 5 grams per kilogram.

Key takeaways

  • Supplementing Nile tilapia diets with 5 grams of chitosan per kilogram significantly improved growth performance, feed conversion, and body composition.
  • Chitosan supplementation enhanced immune markers, significantly increasing serum lysozyme and bactericidal activities before and after bacterial challenge.
  • Diets containing 5 grams of chitosan per kilogram completely prevented mortality following experimental infection with Streptococcus agalactiae, while 3 grams per kilogram markedly reduced it.
  • Chitosan-fed fish maintained lower serum AST and ALT liver enzyme levels after bacterial infection compared to the control group.

Why it matters

Bacterial infections such as Streptococcus agalactiae pose serious risks to farmed fish, leading to high mortality and economic losses. Demonstrating that chitosan acts as a natural feed additive to boost immunity and enhance growth offers fish farmers a viable method to strengthen disease resistance, protect fish health, and potentially reduce reliance on conventional antibiotics in aquaculture.

Commercialisation angle

This research provides applied and tested laboratory evidence for fish feed manufacturers and aquaculture producers looking to formulate functional feeds. Chitosan could be utilised as an immunostimulant and growth-promoting additive in Nile tilapia farming. However, while proven effective in controlled experimental trials, further field validation and economic assessments would be required before broader commercial adoption in commercial fish farming operations.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

The present investigation aimed to evaluate the effect of dietary chitosan supplementation on growth performance, body composition, immune response and histopathology of Nile tilapia, and also the in vitro antibacterial activity of chitosan against Streptococcus agalactiae (S. agalactiae). About 180 fish (average body weight 39.3 ± 0.3 g) were randomly divided into three groups according to chitosan supplementation: control group (basal diet without chitosan), Ch3 group (3 g chitosan/kg diet) and Ch5 group (5 g chitosan/kg diet). Growth performance parameters and body proximate composition were measured before infection but biochemical parameters and lysozyme and antibacterial activities before and after experimental infection. Results of the present investigation showed dietary chitosan (5 g chitosan/kg diet) significantly (p < .05) improved growth performance parameters, body composition (dry matter, crude protein, ether extract, ash, and carbohydrate) and serum biochemistry (total protein, albumin, globulin, with no effect on AST, ALT, urea and creatinine) before infection in Ch5 group than the control. After infection, liver enzymes (serum AST and ALT) were maintained lower in fish fed Ch3 or Ch5 than the control. Serum lysozyme and bactericidal activities significantly increased (p < .05) in chitosan groups before and after the challenge. The mortality rate was markedly reduced in the Ch3 group and prohibited in the Ch5 group after the experimental infection. In conclusion, feeding 3 or 5 g chitosan/kg diet increased the growth rate and improved FCR of Nile tilapia. In addition, it reduced mortality by its antibacterial and immunostimulant effects.

Research topics

  • Aquaculture disease management and microbiota
  • Aquaculture Nutrition and Growth
  • Aquatic life and conservation

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1111/are.14458

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.